Upon completion of this meeting, participants will have increased ability to:
- Recognize the risks and benefits and implement strategies for managing patients with complex cardiovascular disease (CAD) including patients with atrial fibrillation (AF), hypertension, diabetes and heart failure.
- Implement strategies for appropriate stroke and systemic embolism prevention in patients with atrial fibrillation.
- Evaluate efficacy of antiplatelet and antithrombotic therapies in preventing adverse cardiovascular outcomes in patients with CAD and AF.
- Translate evidence-based strategies for prevention, screening and treatment of cardiometabolic risk factors and their comorbidities to their clinical practice.
- Identify evidence based management of cardiovascular morbidity and mortality among patients with diabetes.
- Identify evidence based management of cardiovascular morbidity and mortality among patients with heart failure.
- Identify evidence based management of lipid lowering among patients with established cardiovascular disease.
|
|
|
Saturday, April 29, 2023
|
College of Family Physicians of Canada – Mainpro+:
This one-credit-per-hour Group Learning program meets the certification criteria of the College of Family Physicians of Canada and has been certified by Continuing Professional Development, Temerty Faculty of Medicine, University of Toronto for up to 5.5 Mainpro+ credits.
Royal College of Physicians and Surgeons of Canada – Section 1
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, approved by Continuing Professional Development, Temerty Faculty of Medicine, University of Toronto. You may claim a maximum of 5.5 hours (credits are automatically calculated). |
8:00 am |
Welcome and Introduction |
Kim Connelly, MD |
|
|
Session I: |
Chair: Howard Leong-Poi, MD |
8:10 |
OMG: When and how to start 15 medications in a post-MI patient with co-morbidities Interactive Learning:10 min Q & A by use of on-line polling |
Akshay Bagai, MD |
|
|
8:35 |
Lipid lowering should start with knowing the LDL
Interactive Learning:10 min Q & A by use of on-line polling |
Anatoly Langer, MD |
|
|
9:00 |
Arson in the artery: How to douse the flames with anti-inflammatory therapy?
Interactive Learning:10 min Q & A by use of on-line polling |
Shaun Goodman, MD |
|
|
9:25 |
Cardiomyopathies that can be treated
Interactive Learning:10 min Q & A by use of on-line polling |
Gordon Moe, MD |
|
|
9:50 |
Interactive Learning: Panel Discussion with audience, moderated session, Q&A augmented by use of on-line chat, Q&A or raising of hand |
Faculty |
|
|
10:10 |
NUTRITION BREAK |
|
Session II: |
Chair: Victoria Korley, MD |
10:20 |
Sports cardiology and arrhythmias
Interactive Learning:10 min Q & A by use of on-line polling |
Paul Angaran, MD |
|
|
10:45 |
Hesitation, vacillation: What should we do with (atrial) fibrillation?
Interactive Learning:10 min Q & A by use of on-line polling |
Kaja Konieczny, MD |
|
|
11:10 |
Obesity and CV disease: The “weight” of evidence is finally in our favor!
Interactive Learning:10 min Q & A by use of on-line polling |
Kim Connelly, MD |
|
|
11:35 |
Hot off the press: Clinical trial results that matter in your practice
Interactive Learning:10 min Q & A by use of on-line polling |
Andrew Yan, MD |
|
|
12:00 |
Interactive Learning: Panel Discussion with audience, moderated session, Q&A augmented by use of on-line chat, Q&A or raising of hand |
Faculty |
12:20 |
Lunch |
|
Session III: |
Chair: Geraldine Ong, MD |
12:35 |
Will we ever have diagnosis and treatment standard of care in hypertension?
Interactive Learning:10 min Q & A by use of on-line polling |
Juan Carlos Monge, MD |
|
|
1:00 |
HF management: “Drowning” in a sea of new therapies
Interactive Learning:10 min Q & A by use of on-line polling |
Kim Connelly, MD |
|
|
1:25 |
Therapy convergence: Treat COPD to reduce CV mortality
Interactive Learning:10 min Q & A by use of on-line polling |
Jean Bourbeau, MD |
|
|
1:50 |
Interactive Learning: Panel Discussion with audience, moderated session, Q&A augmented by use of on-line chat, Q&A or raising of hand |
Faculty |
2:15 |
CLOSE |
|
|
|